Search research articles
Contact Us
Filters
Showing results (11-20 of 115) with videos related to
Page
of 12
Sort By:
Annals of Hematology
|
November 2, 2004
A phase I/II study of oral etoposide and idarubicin in elderly patients with high-risk acute myeloid leukemia unable to undergo intensive chemotherapy
Michael Fiegl, Thomas Büchner, Wolfgang Hiddemann, et al.
Indian Journal of Pathology & Microbiology
|
April 21, 2018
Diagnostic and prognostic impact of mucin 1-6 expression in non-small cell lung cancer
William Sterlacci, Michael Fiegl, Lothar Veits, et al.
Leukemia Research
|
August 31, 2006
Cytotoxic activity of the third-generation bisphosphonate zoledronic acid in acute myeloid leukemia
Michael Fiegl, Matthias Juergens, Wolfgang Hiddemann, et al.
Clinical Lung Cancer
|
February 10, 2015
Cardiovascular Comorbidities and Events in NSCLC: Often Underestimated but Worth Considering
Florian Kocher, Michael Fiegl, Michael Mian, et al.
Plos One
|
December 20, 2015
Weight Loss and Decrease of Body Mass Index during Allogeneic Stem Cell Transplantation Are Common Events with Limited Clinical Impact
Christina T Rieger, Isabel Wischumerski, Christian Rust, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
May 27, 2016
Expression of PD-L1 Identifies a Subgroup of More Aggressive Non-Small Cell Carcinomas of the Lung
William Sterlacci, Michael Fiegl, Raoul A Droeser, et al.
Annals of Hematology
|
August 22, 2007
In vitro cross-resistance to nucleoside analogues and inhibitors of topoisomerase 1 and 2 in acute myeloid leukemia
Michael Fiegl, Inka Zimmermann, Isolde Lorenz, et al.
Virchows Archiv : an International Journal of Pathology
|
January 29, 2016
Expression of the CXCR4 ligand SDF-1/CXCL12 is prognostically important for adenocarcinoma and large cell carcinoma of the lung
William Sterlacci, Shereen Saker, Bettina Huber, et al.
Oncology
|
August 26, 2015
NSCLC without Antineoplastic Treatment: Incidence, Characteristics, and Outcome as Outlined in the TYROL Study
Florian Kocher, Fabian Lunger, Andreas Pircher, et al.
Acta Haematologica
|
November 8, 2014
B cell lymphoma with lung involvement: what is it about?
Michael Mian, Ines Wasle, Stefan Gritsch, et al.
Page
of 12
Search research articles
Search
Showing results (11-20 of 115) with videos related to
Sort By:
Page
of 12
Annals of Hematology
|
November 2, 2004
A phase I/II study of oral etoposide and idarubicin in elderly patients with high-risk acute myeloid leukemia unable to undergo intensive chemotherapy
Michael Fiegl, Thomas Büchner, Wolfgang Hiddemann, et al.
Indian Journal of Pathology & Microbiology
|
April 21, 2018
Diagnostic and prognostic impact of mucin 1-6 expression in non-small cell lung cancer
William Sterlacci, Michael Fiegl, Lothar Veits, et al.
Leukemia Research
|
August 31, 2006
Cytotoxic activity of the third-generation bisphosphonate zoledronic acid in acute myeloid leukemia
Michael Fiegl, Matthias Juergens, Wolfgang Hiddemann, et al.
Clinical Lung Cancer
|
February 10, 2015
Cardiovascular Comorbidities and Events in NSCLC: Often Underestimated but Worth Considering
Florian Kocher, Michael Fiegl, Michael Mian, et al.
Plos One
|
December 20, 2015
Weight Loss and Decrease of Body Mass Index during Allogeneic Stem Cell Transplantation Are Common Events with Limited Clinical Impact
Christina T Rieger, Isabel Wischumerski, Christian Rust, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology
|
May 27, 2016
Expression of PD-L1 Identifies a Subgroup of More Aggressive Non-Small Cell Carcinomas of the Lung
William Sterlacci, Michael Fiegl, Raoul A Droeser, et al.
Annals of Hematology
|
August 22, 2007
In vitro cross-resistance to nucleoside analogues and inhibitors of topoisomerase 1 and 2 in acute myeloid leukemia
Michael Fiegl, Inka Zimmermann, Isolde Lorenz, et al.
Virchows Archiv : an International Journal of Pathology
|
January 29, 2016
Expression of the CXCR4 ligand SDF-1/CXCL12 is prognostically important for adenocarcinoma and large cell carcinoma of the lung
William Sterlacci, Shereen Saker, Bettina Huber, et al.
Oncology
|
August 26, 2015
NSCLC without Antineoplastic Treatment: Incidence, Characteristics, and Outcome as Outlined in the TYROL Study
Florian Kocher, Fabian Lunger, Andreas Pircher, et al.
Acta Haematologica
|
November 8, 2014
B cell lymphoma with lung involvement: what is it about?
Michael Mian, Ines Wasle, Stefan Gritsch, et al.
Page
of 12